| single-organism process (GO:0044699) | 0.48 | 29 | GJA8, NHS, CRYGS, WFS1, UNC45B, CRYBA1, VIM, CRYGB, SIPA1L3, GJA3, HSF4, EPHA2, LIM2, AGK, TDRD7, CRYAB, MIP, GCNT2, CRYBA4, BFSP2, PITX3, BFSP1, CHMP4B, CRYGD, MAF, CRYBA2, LSS, CRYBB2, FYCO1 |
| single-organism developmental process (GO:0044767) | 1.49 | 24 | CRYGB, NHS, CRYGS, WFS1, UNC45B, CRYBA1, VIM, GJA8, SIPA1L3, HSF4, EPHA2, LIM2, TDRD7, CRYAB, MIP, GCNT2, CRYBA4, BFSP2, PITX3, BFSP1, CRYGD, CRYBA2, CRYBB2, MAF |
| developmental process (GO:0032502) | 1.36 | 24 | CRYGB, NHS, CRYGS, WFS1, CRYBA4, CRYBA1, VIM, GJA8, SIPA1L3, HSF4, EPHA2, LIM2, TDRD7, CRYAB, MIP, GCNT2, UNC45B, BFSP2, PITX3, BFSP1, CRYGD, CRYBA2, CRYBB2, MAF |
| cellular process (GO:0009987) | 0.26 | 24 | CRYGB, NHS, CRYAA, WFS1, UNC45B, VIM, GJA8, SIPA1L3, GJA3, HSF4, EPHA2, LIM2, AGK, TDRD7, CRYAB, MIP, GCNT2, BFSP2, PITX3, BFSP1, CHMP4B, CRYGD, MAF, FYCO1 |
| anatomical structure development (GO:0048856) | 1.58 | 23 | CRYGB, NHS, CRYGS, WFS1, UNC45B, CRYBA1, VIM, GJA8, SIPA1L3, HSF4, EPHA2, LIM2, CRYAB, MIP, GCNT2, CRYBA4, BFSP2, PITX3, BFSP1, CRYGD, CRYBA2, CRYBB2, MAF |
| single-organism cellular process (GO:0044763) | 0.65 | 23 | CRYGB, NHS, WFS1, UNC45B, VIM, GJA8, SIPA1L3, GJA3, HSF4, EPHA2, LIM2, AGK, TDRD7, CRYAB, MIP, GCNT2, BFSP2, PITX3, BFSP1, CHMP4B, CRYGD, FYCO1, MAF |
| multicellular organismal process (GO:0032501) | 1.45 | 21 | WFS1, GJA3, HSF4, MIP, CRYAA, CRYGB, GCNT2, CRYAB, UNC45B, CRYBA4, EPHA2, CRYBA1, CRYGC, BFSP2, CRYBB1, GJA8, PITX3, CRYBB2, MAF, CRYGD, CRYBB3 |
| system process (GO:0003008) | 2.3 | 16 | CRYAB, GJA8, HSF4, MIP, CRYGC, CRYGB, CRYAA, WFS1, CRYBB1, GJA3, CRYBA1, CRYBA4, BFSP2, CRYBB2, CRYGD, CRYBB3 |
| neurological system process (GO:0050877) | 2.64 | 15 | WFS1, GJA8, HSF4, MIP, CRYGC, CRYGB, CRYAA, CRYBB1, GJA3, CRYBA1, CRYBA4, BFSP2, CRYBB2, CRYGD, CRYBB3 |
| biological regulation (GO:0065007) | 0.39 | 15 | CHMP4B, WFS1, HSF4, MIP, CRYAA, GCNT2, CRYAB, EPHA2, PITX3, CRYBA1, VIM, LSS, TDRD7, MAF, SIPA1L3 |
| visual perception (GO:0007601) | 4.41 | 15 | WFS1, BFSP2, HSF4, MIP, CRYGC, CRYAA, CRYBA1, CRYBB1, GJA3, CRYGB, CRYBA4, GJA8, CRYBB2, CRYGD, CRYBB3 |
| sensory perception (GO:0007600) | 2.93 | 15 | WFS1, BFSP2, HSF4, MIP, CRYGC, CRYAA, CRYBA1, CRYBB1, GJA3, CRYGB, CRYBA4, GJA8, CRYBB2, CRYGD, CRYBB3 |
| sensory perception of light stimulus (GO:0050953) | 4.4 | 15 | WFS1, BFSP2, HSF4, MIP, CRYGC, CRYGB, CRYAA, CRYBB1, GJA3, CRYBA1, CRYBA4, GJA8, CRYBB2, CRYGD, CRYBB3 |
| regulation of biological process (GO:0050789) | 0.45 | 14 | CHMP4B, HSF4, MIP, CRYAB, CRYAA, GCNT2, WFS1, EPHA2, CRYBA1, VIM, PITX3, TDRD7, MAF, SIPA1L3 |
| lens development in camera-type eye (GO:0002088) | 6.09 | 13 | CRYAB, CRYGD, NHS, MIP, CRYGB, CRYBA2, CRYGS, UNC45B, CRYBA1, GJA8, PITX3, MAF, LIM2 |
| cellular developmental process (GO:0048869) | 1.82 | 13 | NHS, HSF4, MAF, CRYGB, EPHA2, VIM, UNC45B, BFSP2, PITX3, TDRD7, BFSP1, CRYGD, SIPA1L3 |
| cellular component organization (GO:0016043) | 1.24 | 12 | CRYAB, GJA8, HSF4, MIP, CRYAA, CHMP4B, CRYGB, EPHA2, VIM, SIPA1L3, BFSP2, LIM2 |
| cellular component organization or biogenesis (GO:0071840) | 1.22 | 12 | CRYAB, GJA8, HSF4, MIP, CRYAA, CHMP4B, CRYGB, EPHA2, VIM, SIPA1L3, BFSP2, LIM2 |
| regulation of cellular process (GO:0050794) | 0.5 | 12 | CHMP4B, WFS1, HSF4, CRYAA, GCNT2, CRYAB, EPHA2, CRYBA1, VIM, PITX3, MAF, SIPA1L3 |
| primary metabolic process (GO:0044238) | 0.69 | 10 | CRYAB, HSF4, GCNT2, CHMP4B, EPHA2, PITX3, WFS1, AGK, LSS, MAF |
| regulation of metabolic process (GO:0019222) | 1.02 | 10 | CRYAB, HSF4, GCNT2, WFS1, EPHA2, CRYBA1, VIM, PITX3, TDRD7, MAF |
| regulation of macromolecule metabolic process (GO:0060255) | 1.08 | 10 | CRYAB, HSF4, GCNT2, WFS1, EPHA2, CRYBA1, VIM, PITX3, TDRD7, MAF |
| organic substance metabolic process (GO:0071704) | 0.63 | 10 | CRYAB, HSF4, GCNT2, CHMP4B, EPHA2, PITX3, WFS1, AGK, LSS, MAF |
| animal organ development (GO:0048513) | 2.53 | 10 | CRYAB, CRYGB, HSF4, WFS1, UNC45B, CRYBA4, SIPA1L3, GJA8, CRYBB2, LIM2 |
| metabolic process (GO:0008152) | 0.58 | 10 | CRYAB, HSF4, GCNT2, CHMP4B, EPHA2, PITX3, WFS1, AGK, LSS, MAF |
| positive regulation of biological process (GO:0048518) | 1.2 | 10 | CHMP4B, HSF4, MIP, GCNT2, WFS1, EPHA2, CRYBA1, VIM, PITX3, MAF |
| negative regulation of biological process (GO:0048519) | 1.33 | 10 | CHMP4B, WFS1, HSF4, CRYAA, GCNT2, CRYAB, EPHA2, CRYBA1, VIM, MAF |
| negative regulation of cellular process (GO:0048523) | 1.41 | 10 | CHMP4B, WFS1, HSF4, CRYAA, GCNT2, CRYAB, EPHA2, CRYBA1, VIM, MAF |
| response to stimulus (GO:0050896) | 1.22 | 9 | CRYAB, CRYGD, GJA3, MIP, CRYAA, WFS1, EPHA2, BFSP2, CRYBB2 |
| cell differentiation (GO:0030154) | 2.14 | 9 | CRYGD, NHS, UNC45B, EPHA2, VIM, PITX3, TDRD7, MAF, SIPA1L3 |
| regulation of primary metabolic process (GO:0080090) | 1.08 | 8 | CRYAB, HSF4, GCNT2, WFS1, EPHA2, CRYBA1, PITX3, MAF |
| sensory organ development (GO:0007423) | 4.82 | 8 | CRYAB, GJA8, HSF4, CRYBA4, SIPA1L3, CRYGB, CRYBB2, LIM2 |
| regulation of cellular metabolic process (GO:0031323) | 1.07 | 8 | CRYAB, HSF4, GCNT2, WFS1, EPHA2, CRYBA1, PITX3, MAF |
| cell development (GO:0048468) | 3.28 | 8 | CRYGB, HSF4, BFSP1, EPHA2, VIM, BFSP2, PITX3, MAF |
| cellular metabolic process (GO:0044237) | 0.69 | 8 | CRYAB, HSF4, GCNT2, WFS1, EPHA2, AGK, PITX3, MAF |
| macromolecule metabolic process (GO:0043170) | 0.83 | 8 | CHMP4B, HSF4, GCNT2, CRYAB, EPHA2, WFS1, PITX3, MAF |
| eye development (GO:0001654) | 5.07 | 8 | CRYAB, GJA8, HSF4, CRYBA4, SIPA1L3, CRYGB, CRYBB2, LIM2 |
| regulation of gene expression (GO:0010468) | 1.37 | 8 | CRYAB, HSF4, GCNT2, WFS1, VIM, PITX3, TDRD7, MAF |
| positive regulation of cellular process (GO:0048522) | 1.3 | 8 | CHMP4B, HSF4, GCNT2, WFS1, EPHA2, CRYBA1, PITX3, MAF |
| cellular component assembly (GO:0022607) | 2.14 | 7 | CHMP4B, HSF4, MIP, CRYAA, CRYAB, GJA8, LIM2 |
| cellular macromolecule metabolic process (GO:0044260) | 0.93 | 7 | CRYAB, HSF4, GCNT2, WFS1, EPHA2, PITX3, MAF |
| protein oligomerization (GO:0051259) | 3.71 | 6 | CHMP4B, HSF4, MIP, CRYAA, CRYAB, GJA8 |
| organic substance biosynthetic process (GO:1901576) | 1.34 | 6 | HSF4, GCNT2, PITX3, AGK, LSS, MAF |
| positive regulation of metabolic process (GO:0009893) | 1.74 | 6 | WFS1, HSF4, GCNT2, VIM, PITX3, MAF |
| single-multicellular organism process (GO:0044707) | 1.78 | 6 | WFS1, GCNT2, UNC45B, EPHA2, PITX3, MAF |
| protein metabolic process (GO:0019538) | 1.45 | 6 | CHMP4B, HSF4, GCNT2, CRYAB, EPHA2, WFS1 |
| protein homooligomerization (GO:0051260) | 4.21 | 6 | CHMP4B, HSF4, MIP, CRYAA, CRYAB, GJA8 |
| protein complex assembly (GO:0006461) | 2.78 | 6 | CHMP4B, HSF4, MIP, CRYAA, CRYAB, GJA8 |
| regulation of response to stimulus (GO:0048583) | 1.54 | 6 | CRYAB, GCNT2, WFS1, EPHA2, CRYBA1, SIPA1L3 |
| macromolecular complex assembly (GO:0065003) | 2.55 | 6 | CHMP4B, HSF4, MIP, CRYAA, CRYAB, GJA8 |
| macromolecular complex subunit organization (GO:0043933) | 2.14 | 6 | CHMP4B, HSF4, MIP, CRYAA, CRYAB, GJA8 |
| biosynthetic process (GO:0009058) | 1.32 | 6 | HSF4, GCNT2, PITX3, AGK, LSS, MAF |
| protein complex subunit organization (GO:0071822) | 2.6 | 6 | CHMP4B, HSF4, MIP, CRYAA, CRYAB, GJA8 |
| anatomical structure morphogenesis (GO:0009653) | 2.53 | 6 | CRYGS, EPHA2, CRYGB, PITX3, TDRD7, SIPA1L3 |
| camera-type eye development (GO:0043010) | 5.36 | 6 | CRYAB, HSF4, CRYBA4, GJA8, CRYBB2, LIM2 |
| positive regulation of macromolecule metabolic process (GO:0010604) | 1.81 | 6 | WFS1, HSF4, GCNT2, VIM, PITX3, MAF |
| negative regulation of metabolic process (GO:0009892) | 1.93 | 5 | MAF, CRYBA1, CRYAB, WFS1, HSF4 |
| positive regulation of cellular metabolic process (GO:0031325) | 1.81 | 5 | PITX3, MAF, WFS1, GCNT2, HSF4 |
| negative regulation of cellular metabolic process (GO:0031324) | 2.01 | 5 | MAF, CRYBA1, CRYAB, WFS1, HSF4 |
| regulation of cellular component organization (GO:0051128) | 2.01 | 5 | EPHA2, VIM, CHMP4B, GCNT2, CRYAB |
| nitrogen compound metabolic process (GO:0006807) | 1.13 | 5 | PITX3, GCNT2, MAF, HSF4, AGK |
| signal transduction (GO:0007165) | 1.28 | 5 | EPHA2, GCNT2, WFS1, VIM, CRYAB |
| regulation of intracellular signal transduction (GO:1902531) | 2.31 | 5 | EPHA2, CRYBA1, GCNT2, WFS1, SIPA1L3 |
| regulation of signaling (GO:0023051) | 1.72 | 5 | EPHA2, CRYBA1, GCNT2, WFS1, SIPA1L3 |
| regulation of cell communication (GO:0010646) | 1.73 | 5 | EPHA2, WFS1, GCNT2, CRYBA1, SIPA1L3 |
| single-organism metabolic process (GO:0044710) | 1.63 | 5 | LSS, CRYAB, GCNT2, AGK, HSF4 |
| regulation of localization (GO:0032879) | 1.94 | 5 | EPHA2, GCNT2, CRYAB, CRYAA, WFS1 |
| negative regulation of macromolecule metabolic process (GO:0010605) | 2.01 | 5 | MAF, CRYBA1, CRYAB, WFS1, HSF4 |
| regulation of signal transduction (GO:0009966) | 1.84 | 5 | EPHA2, WFS1, GCNT2, CRYBA1, SIPA1L3 |
| regulation of protein metabolic process (GO:0051246) | 1.93 | 5 | EPHA2, GCNT2, CRYBA1, CRYAB, WFS1 |
| epithelial cell differentiation (GO:0030855) | 3.98 | 5 | PITX3, EPHA2, TDRD7, MAF, CRYGD |
| regulation of biological quality (GO:0065008) | 1.68 | 5 | MIP, LSS, CHMP4B, GCNT2, WFS1 |
| transport (GO:0006810) | 1.51 | 5 | MIP, CHMP4B, FYCO1, GJA3, GJA8 |
| response to stress (GO:0006950) | 1.8 | 5 | EPHA2, WFS1, CRYAB, CRYGD, GJA3 |
| regulation of multicellular organismal process (GO:0051239) | 1.87 | 5 | EPHA2, GCNT2, CRYBA1, VIM, MAF |
| establishment of localization (GO:0051234) | 1.48 | 5 | MIP, CHMP4B, FYCO1, GJA3, GJA8 |
| localization (GO:0051179) | 1.4 | 5 | MIP, CHMP4B, FYCO1, GJA3, GJA8 |
| organelle organization (GO:0006996) | 2.02 | 5 | CHMP4B, CRYAB, VIM, SIPA1L3, BFSP2 |
| regulation of cellular protein metabolic process (GO:0032268) | 1.99 | 5 | EPHA2, GCNT2, CRYBA1, CRYAB, WFS1 |
| regulation of cell death (GO:0010941) | 2.43 | 5 | CRYAA, CHMP4B, CRYAB, WFS1, CRYBA1 |
| protein folding (GO:0006457) | 4.32 | 4 | CRYAB, CRYAA, WFS1, UNC45B |
| positive regulation of biosynthetic process (GO:0009891) | 2.29 | 4 | PITX3, WFS1, MAF, HSF4 |
| regulation of cellular biosynthetic process (GO:0031326) | 1.38 | 4 | PITX3, WFS1, MAF, HSF4 |
| positive regulation of nitrogen compound metabolic process (GO:0051173) | 2.29 | 4 | PITX3, WFS1, MAF, HSF4 |
| homeostatic process (GO:0042592) | 2.61 | 4 | MIP, CHMP4B, GCNT2, WFS1 |
| cellular biosynthetic process (GO:0044249) | 1.37 | 4 | PITX3, MAF, HSF4, AGK |
| negative regulation of gene expression (GO:0010629) | 2.48 | 4 | WFS1, MAF, CRYAB, HSF4 |
| positive regulation of gene expression (GO:0010628) | 2.35 | 4 | PITX3, MAF, VIM, HSF4 |
| regulation of cell differentiation (GO:0045595) | 2.42 | 4 | GCNT2, VIM, MAF, HSF4 |
| regulation of phosphate metabolic process (GO:0019220) | 2.35 | 4 | EPHA2, CRYBA1, GCNT2, WFS1 |
| organic cyclic compound biosynthetic process (GO:1901362) | 1.66 | 4 | PITX3, LSS, MAF, HSF4 |
| multicellular organism development (GO:0007275) | 2.54 | 4 | PITX3, EPHA2, GCNT2, UNC45B |
| organic cyclic compound metabolic process (GO:1901360) | 1.26 | 4 | PITX3, LSS, MAF, HSF4 |
| cellular protein metabolic process (GO:0044267) | 1.63 | 4 | EPHA2, CRYAB, GCNT2, HSF4 |
| cellular response to stimulus (GO:0051716) | 1.97 | 4 | EPHA2, CRYAB, WFS1, CRYGD |
| regulation of apoptotic process (GO:0042981) | 2.5 | 4 | CRYAA, CRYBA1, CRYAB, WFS1 |
| positive regulation of cellular biosynthetic process (GO:0031328) | 2.3 | 4 | PITX3, WFS1, MAF, HSF4 |
| regulation of cellular macromolecule biosynthetic process (GO:2000112) | 1.46 | 4 | PITX3, WFS1, MAF, HSF4 |
| lens fiber cell differentiation (GO:0070306) | 7.16 | 4 | PITX3, TDRD7, MAF, CRYGD |
| regulation of nucleobase-containing compound metabolic process (GO:0019219) | 1.43 | 4 | PITX3, WFS1, MAF, HSF4 |
| regulation of programmed cell death (GO:0043067) | 2.49 | 4 | CRYAA, CRYBA1, CRYAB, WFS1 |
| regulation of transcription from RNA polymerase II promoter (GO:0006357) | 2.24 | 4 | PITX3, WFS1, MAF, HSF4 |
| protein modification process (GO:0036211) | 1.79 | 4 | EPHA2, CRYAB, GCNT2, HSF4 |
| regulation of protein modification process (GO:0031399) | 2.32 | 4 | EPHA2, CRYBA1, GCNT2, WFS1 |
| regulation of molecular function (GO:0065009) | 1.78 | 4 | EPHA2, WFS1, CRYAB, SIPA1L3 |
| cytoskeleton organization (GO:0007010) | 3.22 | 4 | CRYAB, VIM, BFSP2, SIPA1L3 |
| epithelial cell development (GO:0002064) | 4.92 | 4 | VIM, BFSP1, BFSP2, CRYGB |
| positive regulation of nucleobase-containing compound metabolic process (GO:0045935) | 2.35 | 4 | PITX3, WFS1, MAF, HSF4 |
| regulation of developmental process (GO:0050793) | 2.1 | 4 | EPHA2, VIM, MAF, GCNT2 |
| negative regulation of cell death (GO:0060548) | 2.95 | 4 | CRYAA, CHMP4B, CRYAB, WFS1 |
| regulation of catalytic activity (GO:0050790) | 1.97 | 4 | EPHA2, WFS1, CRYAB, SIPA1L3 |
| regulation of biosynthetic process (GO:0009889) | 1.37 | 4 | PITX3, WFS1, MAF, HSF4 |
| lens fiber cell development (GO:0070307) | 7.53 | 4 | BFSP1, VIM, BFSP2, CRYGB |
| cellular protein modification process (GO:0006464) | 1.79 | 4 | EPHA2, CRYAB, GCNT2, HSF4 |
| regulation of phosphorus metabolic process (GO:0051174) | 2.35 | 4 | EPHA2, CRYBA1, GCNT2, WFS1 |
| macromolecule modification (GO:0043412) | 1.73 | 4 | EPHA2, CRYAB, GCNT2, HSF4 |
| macromolecule biosynthetic process (GO:0009059) | 1.61 | 4 | PITX3, GCNT2, MAF, HSF4 |
| regulation of nucleic acid-templated transcription (GO:1903506) | 1.55 | 4 | PITX3, WFS1, MAF, HSF4 |
| regulation of RNA biosynthetic process (GO:2001141) | 1.55 | 4 | PITX3, WFS1, MAF, HSF4 |
| response to chemical (GO:0042221) | 1.98 | 4 | EPHA2, CRYAB, CRYGD, GJA3 |
| cellular nitrogen compound biosynthetic process (GO:0044271) | 1.59 | 4 | PITX3, MAF, HSF4, AGK |
| regulation of RNA metabolic process (GO:0051252) | 1.52 | 4 | PITX3, WFS1, MAF, HSF4 |
| cellular nitrogen compound metabolic process (GO:0034641) | 1.22 | 4 | PITX3, MAF, HSF4, AGK |
| regulation of transcription, DNA-templated (GO:0006355) | 1.56 | 4 | PITX3, WFS1, MAF, HSF4 |
| regulation of macromolecule biosynthetic process (GO:0010556) | 1.43 | 4 | PITX3, WFS1, MAF, HSF4 |
| regulation of multicellular organismal development (GO:2000026) | 2.31 | 4 | EPHA2, GCNT2, MAF, VIM |
| cellular response to stress (GO:0033554) | 2.51 | 4 | EPHA2, WFS1, CRYAB, CRYGD |
| regulation of nitrogen compound metabolic process (GO:0051171) | 1.36 | 4 | PITX3, WFS1, MAF, HSF4 |
| RNA biosynthetic process (GO:0032774) | 1.84 | 3 | PITX3, MAF, HSF4 |
| negative regulation of biosynthetic process (GO:0009890) | 2.47 | 3 | WFS1, MAF, HSF4 |
| negative regulation of cellular biosynthetic process (GO:0031327) | 2.49 | 3 | WFS1, MAF, HSF4 |
| regulation of transport (GO:0051049) | 2.24 | 3 | WFS1, CRYAA, CRYAB |
| negative regulation of response to stimulus (GO:0048585) | 2.52 | 3 | EPHA2, CRYBA1, WFS1 |
| response to reactive oxygen species (GO:0000302) | 4.5 | 3 | CRYAB, GJA3, CRYGD |
| nucleic acid metabolic process (GO:0090304) | 1.46 | 3 | PITX3, MAF, HSF4 |
| nucleobase-containing compound biosynthetic process (GO:0034654) | 1.72 | 3 | PITX3, MAF, HSF4 |
| negative regulation of cell communication (GO:0010648) | 2.66 | 3 | EPHA2, CRYBA1, WFS1 |
| cellular macromolecule biosynthetic process (GO:0034645) | 1.66 | 3 | PITX3, MAF, HSF4 |
| regulation of hydrolase activity (GO:0051336) | 2.53 | 3 | EPHA2, CRYAB, SIPA1L3 |
| nucleic acid-templated transcription (GO:0097659) | 1.91 | 3 | PITX3, MAF, HSF4 |
| regulation of MAPK cascade (GO:0043408) | 3.22 | 3 | EPHA2, CRYBA1, GCNT2 |
| nucleobase-containing compound metabolic process (GO:0006139) | 1.35 | 3 | PITX3, MAF, HSF4 |
| cell morphogenesis involved in differentiation (GO:0000904) | 4.67 | 3 | EPHA2, CRYGB, SIPA1L3 |
| cell morphogenesis (GO:0000902) | 4.35 | 3 | EPHA2, CRYGB, SIPA1L3 |
| negative regulation of signal transduction (GO:0009968) | 2.75 | 3 | EPHA2, CRYBA1, WFS1 |
| negative regulation of transcription from RNA polymerase II promoter (GO:0000122) | 3.12 | 3 | WFS1, MAF, HSF4 |
| positive regulation of macromolecule biosynthetic process (GO:0010557) | 2.39 | 3 | PITX3, MAF, HSF4 |
| negative regulation of cellular macromolecule biosynthetic process (GO:2000113) | 2.6 | 3 | WFS1, MAF, HSF4 |
| cellular component morphogenesis (GO:0032989) | 3.5 | 3 | EPHA2, SIPA1L3, CRYGB |
| interspecies interaction between organisms (GO:0044419) | 3.08 | 3 | EPHA2, CHMP4B, VIM |
| negative regulation of apoptotic process (GO:0043066) | 3.04 | 3 | WFS1, CRYAA, CRYAB |
| positive regulation of catalytic activity (GO:0043085) | 2.4 | 3 | EPHA2, WFS1, SIPA1L3 |
| positive regulation of molecular function (GO:0044093) | 2.23 | 3 | EPHA2, WFS1, SIPA1L3 |
| phosphorylation (GO:0016310) | 2.63 | 3 | EPHA2, CRYAB, AGK |
| multi-organism process (GO:0051704) | 2.65 | 3 | EPHA2, CHMP4B, VIM |
| negative regulation of programmed cell death (GO:0043069) | 3.02 | 3 | WFS1, CRYAA, CRYAB |
| regulation of cell adhesion (GO:0030155) | 3.27 | 3 | MIP, EPHA2, GCNT2 |
| heterocycle biosynthetic process (GO:0018130) | 1.7 | 3 | PITX3, MAF, HSF4 |
| positive regulation of nucleic acid-templated transcription (GO:1903508) | 2.56 | 3 | PITX3, MAF, HSF4 |
| RNA metabolic process (GO:0016070) | 1.59 | 3 | PITX3, MAF, HSF4 |
| negative regulation of nucleobase-containing compound metabolic process (GO:0045934) | 2.55 | 3 | WFS1, MAF, HSF4 |
| cellular aromatic compound metabolic process (GO:0006725) | 1.3 | 3 | PITX3, MAF, HSF4 |
| regulation of cellular localization (GO:0060341) | 3.03 | 3 | EPHA2, CRYAB, CRYAA |
| negative regulation of nucleic acid-templated transcription (GO:1903507) | 2.71 | 3 | WFS1, MAF, HSF4 |
| negative regulation of RNA biosynthetic process (GO:1902679) | 2.7 | 3 | WFS1, MAF, HSF4 |
| single-organism transport (GO:0044765) | 2.18 | 3 | MIP, CHMP4B, FYCO1 |
| multi-organism cellular process (GO:0044764) | 3.14 | 3 | EPHA2, CHMP4B, VIM |
| negative regulation of transcription, DNA-templated (GO:0045892) | 2.75 | 3 | WFS1, MAF, HSF4 |
| response to oxygen-containing compound (GO:1901700) | 2.57 | 3 | CRYAB, CRYGD, GJA3 |
| negative regulation of nitrogen compound metabolic process (GO:0051172) | 2.47 | 3 | WFS1, MAF, HSF4 |
| single-organism organelle organization (GO:1902589) | 2.68 | 3 | CRYAB, VIM, BFSP2 |
| negative regulation of intracellular signal transduction (GO:1902532) | 3.63 | 3 | EPHA2, CRYBA1, WFS1 |
| movement of cell or subcellular component (GO:0006928) | 2.61 | 3 | EPHA2, VIM, FYCO1 |
| regulation of protein kinase B signaling (GO:0051896) | 4.92 | 3 | EPHA2, CRYBA1, GCNT2 |
| response to oxidative stress (GO:0006979) | 3.9 | 3 | CRYAB, GJA3, CRYGD |
| single-organism localization (GO:1902578) | 2.09 | 3 | MIP, CHMP4B, FYCO1 |
| heterocycle metabolic process (GO:0046483) | 1.31 | 3 | PITX3, MAF, HSF4 |
| regulation of phosphorylation (GO:0042325) | 2.5 | 3 | EPHA2, CRYBA1, GCNT2 |
| transmembrane transport (GO:0055085) | 2.72 | 3 | MIP, GJA3, GJA8 |
| aromatic compound biosynthetic process (GO:0019438) | 1.7 | 3 | PITX3, MAF, HSF4 |
| negative regulation of RNA metabolic process (GO:0051253) | 2.66 | 3 | WFS1, MAF, HSF4 |
| positive regulation of RNA metabolic process (GO:0051254) | 2.51 | 3 | PITX3, MAF, HSF4 |
| regulation of ERK1 and ERK2 cascade (GO:0070372) | 4.23 | 3 | EPHA2, CRYBA1, GCNT2 |
| positive regulation of RNA biosynthetic process (GO:1902680) | 2.54 | 3 | PITX3, MAF, HSF4 |
| phosphate-containing compound metabolic process (GO:0006796) | 2.16 | 3 | EPHA2, CRYAB, AGK |
| positive regulation of transcription from RNA polymerase II promoter (GO:0045944) | 2.81 | 3 | PITX3, MAF, HSF4 |
| transcription, DNA-templated (GO:0006351) | 1.91 | 3 | PITX3, MAF, HSF4 |
| viral process (GO:0016032) | 3.15 | 3 | EPHA2, CHMP4B, VIM |
| phosphorus metabolic process (GO:0006793) | 2.15 | 3 | EPHA2, CRYAB, AGK |
| symbiosis, encompassing mutualism through parasitism (GO:0044403) | 3.15 | 3 | EPHA2, CHMP4B, VIM |
| regulation of protein phosphorylation (GO:0001932) | 2.57 | 3 | EPHA2, CRYBA1, GCNT2 |
| negative regulation of signaling (GO:0023057) | 2.65 | 3 | EPHA2, CRYBA1, WFS1 |
| negative regulation of macromolecule biosynthetic process (GO:0010558) | 2.53 | 3 | WFS1, MAF, HSF4 |
| positive regulation of transcription, DNA-templated (GO:0045893) | 2.56 | 3 | PITX3, MAF, HSF4 |
| anatomical structure homeostasis (GO:0060249) | 4.25 | 2 | CHMP4B, GCNT2 |
| regulation of intracellular transport (GO:0032386) | 3.58 | 2 | CRYAB, CRYAA |
| negative regulation of intracellular transport (GO:0032387) | 5.02 | 2 | CRYAB, CRYAA |
| cellular chemical homeostasis (GO:0055082) | 3.4 | 2 | MIP, WFS1 |
| cell maturation (GO:0048469) | 4.98 | 2 | BFSP1, BFSP2 |
| negative regulation of protein kinase B signaling (GO:0051898) | 6.12 | 2 | EPHA2, CRYBA1 |
| cell surface receptor signaling pathway (GO:0007166) | 2.09 | 2 | EPHA2, GCNT2 |
| enzyme linked receptor protein signaling pathway (GO:0007167) | 3.24 | 2 | EPHA2, GCNT2 |
| establishment of organelle localization (GO:0051656) | 4.15 | 2 | CHMP4B, FYCO1 |
| regulation of cell projection organization (GO:0031344) | 3.38 | 2 | EPHA2, VIM |
| muscle organ development (GO:0007517) | 4.98 | 2 | CRYAB, UNC45B |
| single-organism biosynthetic process (GO:0044711) | 2.8 | 2 | LSS, AGK |
| positive regulation of cell adhesion (GO:0045785) | 3.79 | 2 | MIP, GCNT2 |
| posttranscriptional regulation of gene expression (GO:0010608) | 3.64 | 2 | TDRD7, GCNT2 |
| negative regulation of molecular function (GO:0044092) | 2.74 | 2 | WFS1, CRYAB |
| regulation of cell proliferation (GO:0042127) | 2.41 | 2 | GCNT2, HSF4 |
| negative regulation of transport (GO:0051051) | 3.6 | 2 | CRYAB, CRYAA |
| response to inorganic substance (GO:0010035) | 3.56 | 2 | CRYAB, GJA3 |
| response to organic substance (GO:0010033) | 2.2 | 2 | EPHA2, CRYAB |
| single organism signaling (GO:0044700) | 3.25 | 2 | GJA3, GJA8 |
| organonitrogen compound metabolic process (GO:1901564) | 2.32 | 2 | GCNT2, AGK |
| organonitrogen compound biosynthetic process (GO:1901566) | 2.85 | 2 | GCNT2, AGK |
| intermediate filament cytoskeleton organization (GO:0045104) | 6.04 | 2 | VIM, BFSP2 |
| chemical homeostasis (GO:0048878) | 2.97 | 2 | MIP, WFS1 |
| positive regulation of GTPase activity (GO:0043547) | 3.28 | 2 | EPHA2, SIPA1L3 |
| regulation of anatomical structure morphogenesis (GO:0022603) | 2.79 | 2 | EPHA2, GCNT2 |
| intracellular signal transduction (GO:0035556) | 2.39 | 2 | EPHA2, CRYAB |
| intermediate filament-based process (GO:0045103) | 6.02 | 2 | VIM, BFSP2 |
| developmental maturation (GO:0021700) | 4.7 | 2 | BFSP1, BFSP2 |
| positive regulation of phosphate metabolic process (GO:0045937) | 2.78 | 2 | WFS1, GCNT2 |
| positive regulation of hydrolase activity (GO:0051345) | 2.91 | 2 | EPHA2, SIPA1L3 |
| transcription from RNA polymerase II promoter (GO:0006366) | 3.38 | 2 | PITX3, MAF |
| positive regulation of cellular component organization (GO:0051130) | 2.68 | 2 | EPHA2, GCNT2 |
| organ morphogenesis (GO:0009887) | 3.55 | 2 | PITX3, EPHA2 |
| lipid metabolic process (GO:0006629) | 2.68 | 2 | LSS, AGK |
| programmed cell death (GO:0012501) | 3.1 | 2 | EPHA2, CRYAB |
| regulation of neuron death (GO:1901214) | 4.19 | 2 | CHMP4B, WFS1 |
| negative regulation of neuron death (GO:1901215) | 4.57 | 2 | CHMP4B, WFS1 |
| proteolysis involved in cellular protein catabolic process (GO:0051603) | 3.59 | 2 | CHMP4B, WFS1 |
| intracellular transport (GO:0046907) | 2.67 | 2 | CHMP4B, FYCO1 |
| response to hydrogen peroxide (GO:0042542) | 5.02 | 2 | CRYAB, GJA3 |
| regulation of response to stress (GO:0080134) | 2.53 | 2 | WFS1, CRYAB |
| regulation of cellular response to stress (GO:0080135) | 3.4 | 2 | WFS1, CRYAB |
| regulation of cell motility (GO:2000145) | 3.16 | 2 | EPHA2, GCNT2 |
| positive regulation of protein modification process (GO:0031401) | 2.7 | 2 | WFS1, GCNT2 |
| negative regulation of cellular component organization (GO:0051129) | 3.35 | 2 | CHMP4B, VIM |
| water homeostasis (GO:0030104) | 5.48 | 2 | MIP, WFS1 |
| signaling (GO:0023052) | 3.25 | 2 | GJA3, GJA8 |
| muscle structure development (GO:0061061) | 4.96 | 2 | CRYAB, UNC45B |
| regulation of GTPase activity (GO:0043087) | 3.21 | 2 | EPHA2, SIPA1L3 |
| negative regulation of protein metabolic process (GO:0051248) | 2.82 | 2 | CRYBA1, CRYAB |
| positive regulation of phosphorus metabolic process (GO:0010562) | 2.78 | 2 | WFS1, GCNT2 |
| negative regulation of multicellular organismal process (GO:0051241) | 2.84 | 2 | CRYBA1, VIM |
| positive regulation of protein metabolic process (GO:0051247) | 2.43 | 2 | WFS1, GCNT2 |
| regulation of cell development (GO:0060284) | 3.01 | 2 | VIM, GCNT2 |
| positive regulation of cellular protein metabolic process (GO:0032270) | 2.49 | 2 | WFS1, GCNT2 |
| proteolysis (GO:0006508) | 2.73 | 2 | CHMP4B, WFS1 |
| lipid biosynthetic process (GO:0008610) | 3.49 | 2 | LSS, AGK |
| positive regulation of cell proliferation (GO:0008284) | 3.01 | 2 | GCNT2, HSF4 |
| lens fiber cell morphogenesis (GO:0070309) | 8.34 | 2 | EPHA2, CRYGB |
| maintenance of lens transparency (GO:0036438) | 8.34 | 2 | CHMP4B, GCNT2 |
| positive regulation of cell differentiation (GO:0045597) | 3.01 | 2 | GCNT2, HSF4 |
| regulation of cellular component movement (GO:0051270) | 3.08 | 2 | EPHA2, GCNT2 |
| tissue homeostasis (GO:0001894) | 4.78 | 2 | CHMP4B, GCNT2 |
| negative regulation of cellular protein metabolic process (GO:0032269) | 2.88 | 2 | CRYBA1, CRYAB |
| cellular homeostasis (GO:0019725) | 3.23 | 2 | MIP, WFS1 |
| regulation of protein stability (GO:0031647) | 4.33 | 2 | LSS, WFS1 |
| lens morphogenesis in camera-type eye (GO:0002089) | 7.16 | 2 | PITX3, TDRD7 |
| cell death (GO:0008219) | 3.05 | 2 | EPHA2, CRYAB |
| morphogenesis of an epithelium (GO:0002009) | 4.08 | 2 | EPHA2, CRYGS |
| regulation of growth (GO:0040008) | 3.26 | 2 | WFS1, CRYAB |
| regulation of locomotion (GO:0040012) | 3.12 | 2 | EPHA2, GCNT2 |
| tissue morphogenesis (GO:0048729) | 3.87 | 2 | EPHA2, CRYGS |
| organic substance transport (GO:0071702) | 2.15 | 2 | MIP, CHMP4B |
| protein phosphorylation (GO:0006468) | 2.89 | 2 | EPHA2, CRYAB |
| regulation of cell migration (GO:0030334) | 3.23 | 2 | EPHA2, GCNT2 |
| neuron differentiation (GO:0030182) | 4.17 | 2 | PITX3, EPHA2 |
| apoptotic process (GO:0006915) | 3.14 | 2 | EPHA2, CRYAB |
| establishment of localization in cell (GO:0051649) | 2.47 | 2 | CHMP4B, FYCO1 |
| cell-cell signaling (GO:0007267) | 3.35 | 2 | GJA3, GJA8 |
| cell communication (GO:0007154) | 3.04 | 2 | GJA3, GJA8 |
| organelle localization (GO:0051640) | 3.94 | 2 | CHMP4B, FYCO1 |
| cellular localization (GO:0051641) | 2.32 | 2 | CHMP4B, FYCO1 |
| response to abiotic stimulus (GO:0009628) | 2.8 | 2 | CRYAB, GJA3 |
| microtubule-based process (GO:0007017) | 3.54 | 2 | CRYAB, FYCO1 |
| regulation of cellular component biogenesis (GO:0044087) | 3.08 | 2 | EPHA2, CHMP4B |
| single-organism intracellular transport (GO:1902582) | 3.59 | 2 | CHMP4B, FYCO1 |
| single-organism cellular localization (GO:1902580) | 3.16 | 2 | CHMP4B, FYCO1 |